Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0134716 COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase,...
2018/0134715 Methods and Compositions for Inhibition of Bromodomain-Containing Proteins
The present invention relates to compounds that bind to and otherwise modulate the activity of bromodomain-containing proteins, to processes for preparing...
2018/0134714 COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS
A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to...
2018/0134713 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF ...
The present invention provides processes and intermediates for the preparation of {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl- ...
2018/0134712 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS
The present invention is directed to 6-alkyl dihydropyrazolopyrimidinone compounds of formula (I) which are useful as therapeutic agents for the treatment of...
2018/0134711 New stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical...
2018/0134710 BROMODOMAIN INHIBITORS
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and...
2018/0134709 PURINYL-N-HYDROXYL PYRIMIDINE FORMAMIDE DERIVATIVE, PREPARATION METHODS AND USES THEREOF
The present invention relates to the field of the chemical medicines, and in particular, to purinyl-N-hydroxyl pyrimidine formamide derivatives, a preparation...
2018/0134708 MITRAGYNINE ANALOGS AND USES THEREOF
Described herein are compounds of Formulae (I')-(II'), compounds of Formulae (I)-(II) and pharmaceutically acceptable salts thereof. Compounds of the present...
2018/0134707 AZASPIRO[4.5]DECANE DERIVATIVES AND USE THEREOF
The invention provides azaspiro[4.5]decane derivatives of Formula (A): and pharmaceutically acceptable salts, solvates, hydrates, N-oxides, and diastereomers...
2018/0134706 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
A heterocyclic compound may be represented by Formula 1. The heterocyclic compound may be included in an organic electroluminescence device. The organic...
2018/0134705 NOVEL TRICYCLIC 4-PYRIDONE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS...
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1 to R.sup.7 are as described herein, compositions including the...
2018/0134704 BIARYL KINASE INHIBITORS
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and...
2018/0134703 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
Provided herein are compounds of the Formula I: ##STR00001## or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X.sup.1, X.sup.2, X.sup.3,...
2018/0134702 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
Provided herein are compounds of the Formula I: ##STR00001## and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, X.sup.1,...
2018/0134701 TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS
The present disclosure provides novel imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable salts...
2018/0134700 TYK2 INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated...
2018/0134699 Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
The specification generally relates to compounds of Formula (I): ##STR00001## and pharmaceutically acceptable salts thereof, where Q, R.sup.1, R.sup.2,...
2018/0134698 LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE
Provided herein are novel pyrazolo-quinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with...
2018/0134697 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS
Compounds of formula I (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers...
2018/0134696 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial...
2018/0134695 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
The present invention relates to compounds of formula (I): ##STR00001## in which Y, Y.sub.1, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are defined in the Summary of...
2018/0134694 Compounds for Treating Rac-GTPase Mediated Disorder
This disclosure relates to compositions including certain compounds identified by a quantitative, high throughput assay to be effective in the treatment of a...
2018/0134693 COMPOSITIONS AND METHODS FOR TREATING DISEASES AND CONDITIONS
A compound of Formula II, or a salt, ester, solvate, hydrate or prodrug thereof: ##STR00001## where: X.sup.1 is a branched or unbranched C.sub.1-10 alkyl, ...
2018/0134692 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS
The present invention relates to 1,4-pyridone bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these...
2018/0134691 BARBITURATE AND THIOBARBITURATE COMPOUNDS FOR USE IN CANCER THERAPY
Provided are methods and compositions for use in therapy, and in particular for treating cancer, preferably drug-resistant cancer, and/or radiation resistant...
2018/0134690 INDAZOLES AND USE THEREOF
In one aspect, the present disclosure provides indazoles of Formula I: (I) and the pharmaceutically acceptable salts and solvates thereof, wherein R.sup.3,...
2018/0134689 BENZOCYANINE COMPOUNDS
Compounds useful as labels with properties comparable to known fluorescent compounds. The compounds are conjugated to proteins and nucleic acids for biological...
2018/0134688 NOVEL COMPOUNDS
The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The...
2018/0134687 1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- I - YL) UREAS AS P38 MAPKINASE INHIBITORS
There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy,...
2018/0134686 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES
The invention relates to an organic molecule, especially for use in optoelectronic components. According to the invention, the organic molecule contains a...
2018/0134685 PROCESS FOR THE MANUFACTURING OF MEDICAMENTS
The present invention provides a process for the manufacture of a compound of formula VIIIa and salts forms of VIIIa where R.sup.c is an aryl sulfonic acid ...
2018/0134683 HETEROCYLCIC COMPOUNDS AS IDH2 INHIBITORS
The present invention is directed to novel heterocyclic compounds, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The...
2018/0134682 QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation...
2018/0134681 AMIDE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS INSECTICIDE
An object of the present invention is to provide a compound represented by Formula (1): ##STR00001## wherein A.sub.1, A.sub.2, A.sub.3 and A.sub.4 each ...
2018/0134680 METHOD FOR PRODUCING CYCLIC ESTERS
The invention relates to a method for producing cyclic esters of general formula (I.a) or (I.b) in the presence of at least one high-boiling metal alkoxide...
2018/0134679 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
The invention provides compounds that are useful for treating or preventing cancer.
2018/0134678 PROCESS FOR ISOLATING AND PURIFYING AMBROX
A method of isolating and purifying (-)-Ambrox from a reaction mixture comprising (-)-Ambrox and one or more of the compounds (II), (III) and (IV) ##STR00001##
2018/0134677 NOVEL KCNQ POTASSIUM CHANNEL AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF
The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the...
2018/0134676 PROCESS FOR THE EPOXIDATION OF PROPENE
In a process for the epoxidation of propene, comprising the steps: reacting propene with hydrogen peroxide in the presence of a titanium silicalite catalyst...
2018/0134675 MAGL INHIBITORS
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as...
2018/0134674 MAGL INHIBITORS
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as...
2018/0134673 COMPOUNDS FOR THE TREATMENT OR PREVENTION OF BREAST CANCER
It discloses compounds for the treatment and prevention of breast cancer, which are specifically 2-phenyl benzoselenazole compounds, pharmaceutically...
2018/0134672 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM
The present disclosure pertains to antimicrobial compounds that include silver (Ag) and an s-triazine ring with substitutions at nitrogen or carbon atoms of...
2018/0134671 POLYMORPHS OF A PGES-1 INHIBITING TRIAZOLONE COMPOUND
The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically ...
2018/0134670 CARBOXYLIC ACID URAT1 INHIBITOR CONTAINING DIARYLMETHANE STRUCTURE, PREPARATION METHOD AND USE THEREOF
The present invention relates to the pharmaceutical field for the treatment of hyperuricemia and gout. In particular, the present invention relates to a...
2018/0134669 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
Chemical entities based on quinoxaline that are kinase inhibitors are described. Specifically quinoxaline derivatives of Formula I, containing a diarylamide or...
2018/0134668 QUINAZOLIN CROTYL COMPOUND DIMALEATE CRYSTALS AND PREPARATION METHODS AND USES THEREOF
Disclosed are crystal forms K, E, F and G of the dimaleate of the compound as shown in formula I, and preparation methods and uses thereof. The crystal forms...
2018/0134667 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
The present disclosure discloses compounds capable of modulating the activity of .alpha.-amino-.beta.-carboxymuconic acid semialdehyde decarboxylase (ACMSD),...
2018/0134666 NOVEL CRYSTAL OF URACIL COMPOUND
The present invention provides a crystal that has preferable oral absorption and can be obtained with particularly preferable reproducibility. Provided is a...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.